Physician profile
Elise Clem
NPI 1386038214
$6,761.01
in general payments reported to CMS, 2019-2025
32 companies · $4,794 in 2025
The $4,794 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $340 · 2021: $476 · 2022: $304 · 2023: $177 · 2024: $294 · 2025: $4,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,263 · Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,263.16 |
| Food and Beverage | $1,001.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,485.32 | 2023-2025 | Da Vinci Surgical System |
| Abbvie INC. | $409.72 | 2019-2022 | |
| Therapeuticsmd, INC. | $202.49 | 2019-2022 | |
| Daiichi Sankyo INC. | $160.34 | 2019-2021 | |
| Exeltis, USA INC. | $139.92 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $125.53 | 2020-2025 | Myosure Tissue Removal Device, Aptima, Fluent Fluid Management System |
| Pfizer INC. | $116.72 | 2019-2025 | |
| Shield Therapeutics INC | $103.20 | 2023-2024 | Accrufer |
| Sanara Medtech INC. | $101.29 | 2020 | |
| Aspira Women'S Health INC | $90.90 | 2021 | |
| Scynexis, INC. | $73.54 | 2022 | |
| Sage Therapeutics, LLC | $68.04 | 2023-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $66.80 | 2021 | |
| Minerva Surgical, INC | $63.41 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $57.69 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $52.13 | 2025 | Veozah |
| Agile Therapeutics, INC. | $51.20 | 2021-2024 | Twirla |
| Avion Pharmaceuticals | $41.84 | 2021-2022 | |
| Coopersurgical, INC. | $39.93 | 2023-2025 | Paragard T 380a, Wallach Cryosurgical Equipment |
| Myovant Sciences INC. | $39.83 | 2021 | |
| Sumitomo Pharma America, INC. | $36.45 | 2024-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $32.47 | 2023-2025 | |
| Amag Pharmaceuticals, INC. | $32.37 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $28.85 | 2022 | |
| Merck Sharp & Dohme LLC | $25.21 | 2021-2022 | |
| Organon LLC | $21.64 | 2024 | |
| Supernus Pharmaceuticals, INC. | $19.14 | 2025 | Qelbree |
| Exact Sciences Corporation | $18.09 | 2024 | Cologuard Collection Kit |
| Axonics, INC. | $15.32 | 2024 | Axonics |
| Vertex Pharmaceuticals Incorporated | $14.87 | 2025 | |
| Ethicon US, LLC | $14.06 | 2019 | |
| Lupin INC. | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Clem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.